Plaintiff in 1st Xarelto MDL Case Seeks New Trial, Says Evidence Improperly Excluded

NEW ORLEANS — The plaintiff in the first bellwether case in the Xarelto multidistrict litigation is seeking a new trial in the wake of a defense verdict, arguing that the Louisiana federal court erred in excluding evidence concerning the viability of testing to identify patients with a high risk of bleeding.

In a June 12 motion filed in the U.S. District Court for the Eastern District of Louisiana, Joseph Boudreaux argued that he should have been permitted to question a defense expert about her failure to consider a peer-reviewed publication that touted the Neoplastin PT test as a reliable screening …